granisetron has been researched along with Breast Neoplasms in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (41.18) | 18.2507 |
| 2000's | 10 (29.41) | 29.6817 |
| 2010's | 9 (26.47) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Aogi, K; Baba, M; Chiba, Y; Fujiwara, K; Hirano, G; Imamura, CK; Imoto, S; Matsumoto, K; Matsuura, K; Miyazaki, C; Naito, Y; Osaki, A; Saeki, T; Sato, K; Takahashi, M; Takano, T; Tamura, K; Tokunaga, S; Yanagihara, K | 1 |
| Araz, M; Artac, M; Beypinar, I; Inci, F; Karaagac, M; Koral, L; Korkmaz, L; Uysal, M | 1 |
| Hatake, K; Ito, Y; Nakayama, Y; Takahashi, S; Tanabe, M | 1 |
| Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L | 1 |
| Kinoshita, H; Matsumoto, Y; Shimizu, C; Shimizu, K; Uchitomi, Y | 1 |
| Curran, MP; Duggan, ST | 1 |
| Hassan, BA; Yusoff, ZB | 1 |
| Abolhasani, E; Hashemian, F; Panahi, Y; Saadat, A; Sahebkar, A; Taghikhani, M | 1 |
| Bordeleau, L; Clemons, M; Dodd, A; Goodwin, P; Pond, G; Seruga, B; Tannock, IF; Vardy, J; Warr, D | 1 |
| Eksborg, S; Lönnqvist, PA; Öbrink, E; Oddby-Muhrbeck, E; Rotstein, S | 1 |
| Daimon, T; Hayashi, H; Inoue, K; Itoh, K; Iwabe, Y; Kim, YI; Nakamichi, H; Suwa, K; Tsuji, D; Yoshida, M | 1 |
| Coop, AJ; Dempsey, CL; Eberhardt, DR; Farley, PA; O'Briant, S; Shillington, A | 1 |
| Bhatnagar, S; Dua, N; Mishra, S; Singhal, AK | 1 |
| Abali, H; Guler, N; Oyan, B | 1 |
| Kim, SJ; Miyoshi, Y; Noguchi, S; Taguchi, T; Tamaki, Y; Tanji, Y | 1 |
| Ito, Y; Tomono, H; Watanabe, T | 1 |
| Buchanan, D; Muirhead, K | 1 |
| Barbaud, A; Bursztejn, AC; Cuny, JF; Schmutz, JL; Tréchot, P | 1 |
| Ang, PT; Khoo, KS; Tan, EH | 1 |
| Ionta, MT; Massidda, B | 1 |
| Quigley, C | 1 |
| Contu, A; Depenni, R; Donati, D; Maestri, A; Meriggi, F; Olmeo, N; Piro, S; Sabbatini, R; Silingardi, V; Zaniboni, A | 1 |
| Hatano, Y; Kato, N; Okuyama, N; Park, Y; Sasamoto, S; Yamazaki, S | 1 |
| Sun, Y; Zhang, H; Zhang, P | 1 |
| Fujii, Y; Tanaka, H; Toyooka, H | 1 |
| Aznar, E; Climent, MA; Guillem, V; Olmos, T; Palau, J; Ruiz, A; Soriano, V | 1 |
| Chow, LW; Poon, RT | 1 |
| Bolwell, B; Boparai, N; Jones, E; Kalaycio, M; Mendez, Z; Overmoyer, B; Pohlman, B | 1 |
| Birch, R; Buckner, CD; Carson, K; Weaver, CH | 1 |
| Brown, RS; Brown, TK; Gaze, MN; Hoare, D | 1 |
| Granisétron, PK; Mabro, M | 1 |
| Andersen, LJ; Dombernowsky, P; Havsteen, H; Herrstedt, J; Kjaer, M; Kjaerbøl, AG; Langer, SW; Lund, H; Sigsgaard, T | 1 |
| Andersen, O; Christensen, P; Dombernowsky, P; Herrstedt, J; Sigsgaard, T | 1 |
| Fujii, Y; Kawasaki, T; Tanaka, H | 1 |
1 review(s) available for granisetron and Breast Neoplasms
| Article | Year |
|---|---|
Transdermal granisetron.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Molecular Structure; Nausea; Receptors, Neurokinin-1; Receptors, Serotonin; Remission Induction; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2009 |
21 trial(s) available for granisetron and Breast Neoplasms
| Article | Year |
|---|---|
A double-blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy-induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophospham
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Palonosetron; Patient Reported Outcome Measures; Vomiting | 2020 |
A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study.
Topics: Adult; Aged; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Dexamethasone; Female; Granisetron; Humans; Isoquinolines; Middle Aged; Morpholines; Palonosetron; Quinuclidines; Retrospective Studies; Treatment Outcome; Vomiting | 2015 |
Transdermal granisetron.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Humans; Infusions, Intravenous; Male; Molecular Structure; Nausea; Receptors, Neurokinin-1; Receptors, Serotonin; Remission Induction; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2009 |
Effect of ginger on acute and delayed chemotherapy-induced nausea and vomiting: a pilot, randomized, open-label clinical trial.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Middle Aged; Nausea; Pilot Projects; Prevalence; Severity of Illness Index; Taxoids; Time Factors; Vomiting; Zingiber officinale | 2012 |
A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Dexamethasone; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Humans; Middle Aged; Quality of Life | 2012 |
Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide.
Topics: Adult; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cancer Care Facilities; Cohort Studies; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Granisetron; Humans; Infusions, Intravenous; Injections, Intravenous; Logistic Models; Middle Aged; Nausea; Ondansetron; Retrospective Studies; Time Factors; Vomiting | 2004 |
Granisetron and ondansetron for prevention of nausea and vomiting in patients undergoing modified radical mastectomy.
Topics: Adult; Aged; Analysis of Variance; Anesthesia, General; Breast Neoplasms; Chi-Square Distribution; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Granisetron; Humans; Infusions, Intravenous; Mastectomy, Modified Radical; Middle Aged; Nausea; Ondansetron; Preoperative Care; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting | 2004 |
Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer.
Topics: Alprazolam; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Drug Interactions; Drug Therapy, Combination; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Hypnotics and Sedatives; Middle Aged; Vomiting | 2005 |
[The feasibility of FEC (75) as adjuvant chemotherapy for Japanese breast cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dexamethasone; Diarrhea; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Fluorouracil; Granisetron; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neutropenia; Vomiting, Anticipatory | 2005 |
Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Constipation; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Flushing; Granisetron; Headache; Humans; Injections, Intravenous; Metoclopramide; Middle Aged; Nausea; Tablets; Vomiting | 1994 |
Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cost-Benefit Analysis; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Granisetron; Granulocyte Colony-Stimulating Factor; Humans; Indoles; Injections, Intravenous; Methotrexate; Middle Aged; Ondansetron; Serotonin Antagonists; Tropisetron; Vomiting | 1996 |
A comparison of the antiemetic efficacy and safety of intramuscular and intravenous formulations of granisetron in patients receiving moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Cross-Over Studies; Female; Granisetron; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Middle Aged; Nausea; Neoplasms; Treatment Outcome; Vomiting | 1995 |
[A randomized trial of tropisetron in the prophylaxis of nausea and vomiting induced by chemotherapy].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Female; Granisetron; Humans; Indoles; Lung Neoplasms; Lymphoma; Male; Middle Aged; Tropisetron; Vomiting | 1996 |
Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo.
Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Droperidol; Female; Granisetron; Humans; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Vomiting | 1998 |
Comparison of antiemetic efficacy of granisetron and ondansetron in Oriental patients: a randomized crossover study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Over Studies; Double-Blind Method; Granisetron; Hong Kong; Humans; Middle Aged; Nausea; Ondansetron; Vomiting | 1998 |
Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Double-Blind Method; Female; Granisetron; Humans; Infusions, Intravenous; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cyclophosphamide; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Middle Aged; Nausea; Thiotepa | 1998 |
[Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Breast Neoplasms; Drug Therapy, Combination; Female; Granisetron; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Vomiting | 1999 |
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dopamine Antagonists; Double-Blind Method; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Methotrexate; Middle Aged; Nausea; Prednisolone; Serotonin Antagonists; Vomiting | 1999 |
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Therapy, Combination; Female; Glucocorticoids; Granisetron; Humans; Isonipecotic Acids; Middle Aged; Nausea; Prednisolone; Treatment Outcome; Vomiting | 2000 |
Preoperative oral granisetron for the prevention of postoperative nausea and vomiting after breast surgery.
Topics: Adult; Aged; Antiemetics; Breast Neoplasms; Female; Granisetron; Humans; Mastectomy, Radical; Middle Aged; Postoperative Nausea and Vomiting; Preoperative Care | 2001 |
13 other study(ies) available for granisetron and Breast Neoplasms
| Article | Year |
|---|---|
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Epirubicin; Female; Granisetron; Humans; Middle Aged; Nausea; Palonosetron; Prospective Studies; Vomiting | 2019 |
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron | 2015 |
Suicide associated with corticosteroid use during chemotherapy: case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Depression, Chemical; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Prochlorperazine; Suicide | 2010 |
Genetic polymorphisms in the three malaysian races effect granisetron clinical antiemetic actions in breast cancer patients receiving chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cytochrome P-450 CYP3A; Female; Follow-Up Studies; Granisetron; Humans; Longitudinal Studies; Malaysia; Middle Aged; Nausea; Neoplasm Staging; Polymorphism, Genetic; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2011 |
Is there an association between PONV and chemotherapy-induced nausea and vomiting?
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease Resistance; Droperidol; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Mastectomy; Methotrexate; Metoclopramide; Middle Aged; Models, Biological; Narcotics; Nausea; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Risk Factors; Vomiting | 2013 |
Association of ABCB1 polymorphisms with the antiemetic efficacy of granisetron plus dexamethasone in breast cancer patients.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Granisetron; Humans; Polymorphism, Single Nucleotide | 2013 |
[Successful antiemetic treatment of TSUMURA Rikkunshi-to Extract Granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient].
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drugs, Chinese Herbal; Epirubicin; Female; Fluorouracil; Granisetron; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Segmental; Metoclopramide; Middle Aged | 2006 |
Intractable nausea and vomiting successfully related with granisetron 5-hydroxytryptamine type 3 receptor antagonists in Palliative Medicine.
Topics: Antiemetics; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Palliative Care; Treatment Outcome; Vomiting | 2007 |
Cutaneous adverse drug reactions during chemotherapy: consider non-antineoplastic drugs.
Topics: Adult; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Cross Reactions; Drug Eruptions; Female; Glucocorticoids; Granisetron; Humans; Indoles; Male; Middle Aged; Ondansetron; Pancreatic Neoplasms; Prednisolone; Skin Tests; Tropisetron; Urticaria | 2008 |
5HT3 receptor antagonists and pruritus due to cholestasis.
Topics: Aged; Breast Neoplasms; Cholestasis; Female; Granisetron; Humans; Liver Neoplasms; Ondansetron; Pruritus; Serotonin Antagonists | 1996 |
[Antiemetic efficacy of granisetron in repeated CAF chemotherapy after breast cancer operation].
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Granisetron; Humans; Middle Aged; Nausea; Postoperative Period; Vomiting | 1997 |
The antiemetic efficacy of granisetron plus dexamethasone, haloperidol and loracepam in breast cancer patients treated with high-dose chemotherapy with peripheral blood stem-cell support.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Granisetron; Haloperidol; Hematopoietic Stem Cell Transplantation; Humans; Lorazepam; Middle Aged; Nausea; Palliative Care; Treatment Outcome; Vomiting | 1998 |
An audit of antiemetic use with CMF chemotherapy.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Female; Fluorouracil; Granisetron; Humans; Medical Records; Methotrexate; Metoclopramide; Retrospective Studies; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |